AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11703374
Drug: HAART with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAART with plasma HIV-1 RNA suppressed to below 500 copies/ml (group 1)
Trial: 7703514
Drug: Ileo-rectal anastomosis
RxNorm normalized name: POUCH,ILEO DISPOSABLE GRICKS #GR4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ileo-rectal anastomosis (IRA)
Trial: 29365294
Drug: Solanezumab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solanezumab (400 mg, intravenously every 4 weeks for 76 weeks)
Trial: 23965396
Drug: BMS-927711 75
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS-927711 75 mg
Trial: 23965396
Drug: BMS-927711 150
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS-927711 150 mg
Trial: 23965396
Drug: BMS-927711 300
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS-927711 300 mg
Trial: 23965396
Drug: BMS-927711 (25-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-927711 (25-600 mg)
Trial: 20400912
Drug: Pantoprazole 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 1.2 mg/kg/day for 4 weeks
Trial: 17910747
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg plus hydrochlorothiazide 12.5 mg (T/HCTZ)
Trial: 16260435
Drug: Multisystemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic therapy (MST) for 6 months
Trial: 10525755
Drug: Venlafaxine 18.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 18.75 mg
Trial: 10525755
Drug: Paroxetine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 5 mg
Trial: 1771173
Drug: Aspartame (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (500 mg)
Trial: 1771173
Drug: Sucrose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (100 g)
Trial: 7067996
Drug: Self-administered, mailed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered, mailed questionnaires
Trial: 31693974
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IL-6, IL-8, ST2, sTNFR2, IL-12, and TNF-α
Trial: 24629994
Drug: Monovalent human-bovine
RxNorm normalized name: human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent human-bovine rotavirus vaccine (116E)
Trial: 19702643
Drug: Total Therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Therapy 3 (TT3) with added bortezomib
Trial: 15151172
Drug: TMZ MR
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ MR 35 mg b.i.d.
Trial: 15151172
Drug: TMZ IR
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ IR 20 mg t.i.d.
Trial: 15151172
Drug: TMZ MR
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ MR in dogs and pigs (multiple dose simulations)
Trial: 11579646
Drug: Ketanserin gel
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin gel (2%)
Trial: 11579646
Drug: Clioquinol cream
RxNorm normalized name: Clioquinol Cream
DrugBank: Clioquinol (DB04815)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clioquinol cream and/or Lassar paste
Trial: 9675961
Drug: Pr IR
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pr IR 150 mg x 3
Trial: 9675961
Drug: Pr SR
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pr SR 325 mg x 2
Trial: 9675961
Drug: Pr SR
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pr SR 225 mg x 2
Trial: 8017357
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 micrograms, twice daily for 2 months)
Trial: 2872793
Drug: Intravenous hydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydralazine (5 to 30 mg)
Trial: 2872793
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (20 to 80 mg)
Trial: 22588154
Drug: CT screening
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT screening with five annual low-dose CT scans
Trial: 20718170
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg orally
Trial: 20718170
Drug: Parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib 40 mg intravenously
Trial: 18572758
Drug: Gas-powered, needle-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gas-powered, needle-free injection device (NFID)
Trial: 18569233
Drug: Dose-response slope
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose-response slope
Trial: 9084344
Drug: Piracetam 4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam 4.8 g/day with intensive language therapy for 6 weeks
Trial: 9084344
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with intensive language therapy for 6 weeks
Trial: 8251285
Drug: Edrophonium 0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 0.1, 0.2, 0.4, or 1 mg kg‐1
Trial: 8251285
Drug: Neostigmine 0.005,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.005, 0.01, 0.02, or 0.05 mg kg‐1
Trial: 31256599
Drug: Conjugated Linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated Linoleic Acid (CLA) supplementation (3000 mg daily in 3 doses)
Trial: 30029523
Drug: High-dose 'Benifuuki'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose 'Benifuuki' extract (676 mg of catechins)
Trial: 30029523
Drug: Low-dose 'Benifuuki'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose 'Benifuuki' extract (322 mg of catechins)
Trial: 22404221
Drug: Swallowing exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swallowing exercise (placing a milk bolus of 0.05‐0.2 mL on the tongue)
Trial: 15482044
Drug: Alcohol behavioral
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol behavioral couples therapy (ABCT)
Trial: 15482044
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (ABCT, RP/ABCT, AA/ABCT)
Trial: 21236721
Drug: High-dose/short-term hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose/short-term hepatitis B vaccination schedules
Trial: 21236721
Drug: New immunogenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New immunogenic formulations of hepatitis B vaccine
Trial: 9596305
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg twice a day for 3 days
Trial: 9596305
Drug: Salmeterol 100
RxNorm normalized name: fluticasone-salmeterol 100 mcg-50 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 100 microg twice a day for 3 days
Trial: 7829764
Drug: TRH tests
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH tests administered before, during, and after ECT
Trial: 18403102
Drug: Irrigation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigation with ISO 0.1 microg/mL
Trial: 16788315
Drug: Standard haemostatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard haemostatic replacement therapy (placebo)
Trial: 10955434
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg oestradiol implants
Trial: 9925060
Drug: 3 mg/d
RxNorm normalized name: Neupro 3 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/d of beclomethasone dipropionate (BDP)
Trial: 7572574
Drug: rTPA alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTPA alone (100 mg in 3 hours)
Trial: 2180474
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with oxprenolol or oxprenolol plus dihydralazine
Trial: 2180474
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with oxprenolol
Trial: 30225529
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg/day for 8 weeks
Trial: 28358815
Drug: Azathioprine 50mg
RxNorm normalized name: AZATHIOPRINE 50MG TAB
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine 50mg for 24, 36 or 48 weeks with steroid treatment (oral prednisolone for 20 weeks)
Trial: 28358815
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment (oral prednisolone for 20 weeks)
Trial: 28358815
Drug: Azathioprine treatment
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine treatment for 48 weeks
Trial: 28358815
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with steroids and azathioprine
Trial: 25981347
Drug: Cocoa flavanols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa flavanols (CF) at doses of 5.3 mg and 10.7 mg total CF/kg body weight (BW)
Trial: 25981347
Drug: Acetaminophen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1 g) as control
Trial: 21415263
Drug: Supervised treadmill
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supervised treadmill training for 12 weeks at home, exercising twice a week at an intensity of 66% of HR(peak)
Trial: 18021477
Drug: Taxanes in
RxNorm normalized name: Taxanes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxanes in both treatment arms
Trial: 3016080
Drug: Topical human
RxNorm normalized name: thrombin topical human topical solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical human fibroblast interferon
Trial: 31516094
Drug: Probiotics +
RxNorm normalized name: Culturelle Probiotics + Multivitamin Gummies (Mixed Berry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics + sertraline (PS)
Trial: 31516094
Drug: Sertraline alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline alone (S)
Trial: 31806719
Drug: Individualised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised treatment targeting treatable traits
Trial: 28763875
Drug: Nattokinase (NK)
RxNorm normalized name: Nattokinase
DrugBank: Nattokinase (DB15329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nattokinase (NK) at a daily dose of 6000 FU for 26 weeks
Trial: 28763875
Drug: Statin (simvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin (simvastatin 20 mg) daily for 26 weeks
Trial: 26268133
Drug: 2h abbreviated
RxNorm normalized name: (2H)-Phthalazinone hydrazone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2h abbreviated fasting with oral ingestion of a carbohydrate and protein solution
Trial: 21732797
Drug: Insulin bolus-patch
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin bolus-patch
Trial: 10868638
Drug: Quadruple induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple induction therapy (tacrolimus, azathioprine, ALG Merieux, and prednisolone)
Trial: 10868638
Drug: Dual induction
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual induction therapy (tacrolimus and prednisolone)
Trial: 10868638
Drug: Quadruple induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple induction therapy
Trial: 10868638
Drug: Dual induction
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual induction therapy
Trial: 8218538
Drug: rhIL-3 (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-3 (highest dose levels)
Trial: 3957502
Drug: Flunarizine 20
RxNorm normalized name: flunarizine
DrugBank: Flunarizine (DB04841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 20 mg/per os/day for 14 days, followed by 10 mg/per os/day up to 120 days
Trial: 2454374
Drug: Carvedilol i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol i.v. (15 mg)
Trial: 2454374
Drug: Labetalol i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol i.v. (40 mg and 80 mg)
Trial: 31554874
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (group A with 13 cases)
Trial: 31554874
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (group A)
Trial: 25738668
Drug: Goserelin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin with standard chemotherapy
Trial: 23385648
Drug: Bisoprolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (5 mg, titrated to 10 mg)
Trial: 23385648
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg, titrated to 100 mg)
Trial: 26618715
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg GOE
Trial: 26618715
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg GOE
Trial: 19752363
Drug: 5g IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5g IV MgSO(4) followed by daily 4-hour infusions from postoperative day 1 until postoperative day 4
Trial: 7874899
Drug: 0.50 mL
RxNorm normalized name: witch hazel 0.50 mL in 1 mL TOPICAL SOLUTION [Medicated Pads]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mL normal saline injection
Trial: 7874899
Drug: 0.75 mL
RxNorm normalized name: ethanol 0.75 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mL normal saline injection
Trial: 7874899
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL normal saline injection
Trial: 7874899
Drug: 0.25 mL
RxNorm normalized name: mineral oil 0.25 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mL normal saline injection
Trial: 7874899
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injections (all volumes)
Trial: 763213
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 250 mg of lidocaine in a 10% solution into the deltoid muscle
Trial: 763213
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 250 mg of lidocaine in a 10% solution into the lateral vastus muscle
Trial: 31503180
Drug: PIP in
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PIP in combination with major depressive disorder (MDD)
Trial: 29050954
Drug: Stereotactic body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body radiation therapy (SBRT) with a target dose of 48-54 Gy in six fractions
Trial: 25562685
Drug: Paliperidone monthly
RxNorm normalized name: Paliperidone
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Paliperidone monthly
Trial: 22431145
Drug: VPT/CEM (Vital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VPT/CEM (Vital Pulp Therapy with Calcium-Enriched Mixture Cement)
Trial: 19530584
Drug: Epidural nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural nalbuphine 5 mg
Trial: 19530584
Drug: Epidural nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural nalbuphine 10 mg
Trial: 11559309
Drug: Subcutaneous apomorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous apomorphine hydrochloride (2-10 mg, n = 20)
Trial: 11559309
Drug: Subcutaneous apomorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous apomorphine hydrochloride (2-10 mg)
Trial: 9733667
Drug: Oral ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ifosfamide with methylene blue (50 mg po 3 times daily)
Trial: 9733667
Drug: Intravenous ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ifosfamide (one of the first two cycles)
Trial: 9733667
Drug: Methylene blue
RxNorm normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylene blue administration
Trial: 3184889
Drug: Cocaine 15
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine 15 mg
Trial: 3184889
Drug: Cocaine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (15 mg and 40 mg combined)
Trial: 25163819
Drug: 17OHPC (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17OHPC (250 mg weekly injections)
Trial: 16518962
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (zidovudine/lamivudine/efavirenz)
Trial: 16518962
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (abacavir/lamivudine/zidovudine/tenofovir)
Trial: 14734394
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (1mEq/l) administration
Trial: 14734394
Drug: Historical factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Historical factors (chief complaint, medical history, specific disease conditions, overall drug use)
Trial: 7924776
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (720 pM.m-2.min-1) during hypoglycemia (target plasma glucose, 2.8 mM)
Trial: 7924776
Drug: Increased insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased insulin infusion rate (1,440 pM.m-2.min-1)
Trial: 2729537
Drug: Intratracheal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratracheal administration of 10 ml 0.9% NaCl (group 4)
Trial: 30938035
Drug: FBG target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FBG target of 3.9 < FBG ≤5.6 mmol/L (Group 1)
Trial: 30938035
Drug: FBG target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FBG target of 3.9 < FBG ≤6.1 mmol/L (Group 2)
Trial: 30938035
Drug: FBG target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FBG target of 3.9 < FBG ≤7.0 mmol/L (Group 3)
Trial: 23126492
Drug: Apical box
RxNorm normalized name: ALLERGENIC EXTRACT, BOX ELDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical box preparation (size #60)
Trial: 23126492
Drug: Apical cone
RxNorm normalized name: Pinus strobus cone extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical cone preparation (apical size #25)
Trial: 19561263
Drug: Immunoembolization (IE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunoembolization (IE) with granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) at high-dose (>or=1500 microg)
Trial: 8779400
Drug: Randomized studies
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized studies in emergency medicine
Trial: 2008953
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IT morphine and epidural bupivacaine
Trial: 7035953
Drug: Cyclophosphamide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (2 mg per kilogram of body weight per day) with prednisone in tapering doses
Trial: 7035953
Drug: Chlorambucil (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorambucil (0.15 mg per kilogram per day) with prednisone in tapering doses
Trial: 7035953
Drug: Cytotoxic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic drugs (Cyclophosphamide or Chlorambucil)
Trial: 11524351
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 2% lidocaine
Trial: 26099868
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 25-mg tramadol
Trial: 26099868
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 2% lidocaine + 25-mg tramadol